Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease  

作　　者：Kadja Luana Chagas Monteiro Marcone Gomes dos Santos Alcântara Thiago Mendonça de Aquino Edeildo Ferreira da Silva-Júnior 

机构地区：[1]Laboratory of Medicinal Chemistry,Institute of Pharmaceutical Sciences,Federal University of Alagoas,Maceió,Brazil [2]Chemistry and Biotechnology Institute,Federal University of Alagoas,Maceió,Brazil

出　　处：《Neural Regeneration Research》2021年第5期990-991,共2页中国神经再生研究（英文版）

摘　　要：Alzheimer’s disease(AD)is a chronic neurodegenerative disease,which is difficult to diagnose in its early stages.It is associated with aging and consists of a decline in cognitive functions,memory,and other mental activities.Some pathophysiological markers are associated with AD progression and worsening,such as the deposition and intracellular accumulation of senile plaques containing amyloid-β(Aβ)peptides,and tau protein hyperphosphorylation,leading to the formation of neurofibrillary tangles.

关 键 词：ALZHEIMER AΒ TAU 

分 类 号：R285[医药卫生—中药学]